| Acute and chronic effects of endocardial radiofrequency ablation of septal hypertrophy in HOCM T Lawrenz, D Lawin, K Radke, C Stellbrink Journal of Cardiovascular Electrophysiology 32 (10), 2617-2624, 2021 | 16 | 2021 |
| Change in indication for cardiac resynchronization therapy? D Lawin, C Stellbrink European Journal of Cardio-Thoracic Surgery 55 (Supplement_1), i11-i16, 2019 | 11 | 2019 |
| Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy D Lawin, T Lawrenz, K Marx, NB Danielsmeier, MR Poudel, C Stellbrink Heart 108 (20), 1623-1628, 2022 | 7 | 2022 |
| Safety and efficacy of alcohol septal ablation in adolescents and young adults with hypertrophic obstructive cardiomyopathy D Lawin, T Lawrenz, K Radke, C Stellbrink Clinical Research in Cardiology, 1-11, 2022 | 6 | 2022 |
| Cannabis-induced recurrent myocardial infarction in a 21-year-old man: a case report D Lawin, T Lawrenz, A Tego, C Stellbrink European Heart Journal-Case Reports 4 (3), 1-5, 2020 | 5 | 2020 |
| Use of digital health applications for the detection of atrial fibrillation D Lawin, S Kuhn, S Schulze Lammers, T Lawrenz, C Stellbrink Herzschrittmachertherapie+ Elektrophysiologie 33 (4), 373-379, 2022 | 3 | 2022 |
| Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT Survey II D Lawin, CW Israel, C Linde, C Normand, K Dickstein, C Lober, AK Gitt, ... Clinical Research in Cardiology 109, 832-844, 2020 | 3 | 2020 |
| Cryoballoon ablation of atrial fibrillation in octogenarians: one year outcomes from the cryo global registry D Lawin, T Lawrenz, KRJ Chun, HE Lim, V Obidigbo, JM Selma, ... Journal of Interventional Cardiac Electrophysiology, 1-11, 2023 | 2 | 2023 |
| Digital health applications from a government-regulated directory of reimbursable health apps in Germany—a systematic review for evidence and bias F Dittrich, A Mielitz, E Pustozerov, D Lawin, U von Jan, UV Albrecht Mhealth 9, 2023 | 2 | 2023 |
| Alcohol septal ablation in patients aged 75 years or older with hypertrophic obstructive cardiomyopathy D Lawin, C Stellbrink, E Stellbrink, B Buck, MR Poudel, A Tego, K Marx, ... Heart 109 (23), 1778-1784, 2023 | 1 | 2023 |
| Prolonged mHealth-Based Arrhythmia Monitoring in Patients With Hypertrophic Cardiomyopathy (HCM-PATCH): Protocol for a Single-Center Cohort Study SC Schulze Lammers, T Lawrenz, D Lawin, A Hoyer, C Stellbrink, ... JMIR Research Protocols 12, 2023 | 1 | 2023 |
| Evidence of Digital Health Applications from a State-Regulated Repository for Reimbursable Health Applications in Germany UV Albrecht, U Von Jan, D Lawin, E Pustozerov, F Dittrich Caring is Sharing–Exploiting the Value in Data for Health and Innovation …, 2023 | 1 | 2023 |
| Case report of a patient with congenital long QT syndrome Type 2 presenting with electrical storm: do not judge a book by its cover! D Lawin, MR Poudel, T Lawrenz, C Stellbrink European Heart Journal-Case Reports 6 (9), ytac369, 2022 | 1 | 2022 |
| Mobile health for detection of atrial fibrillation-Status quo and perspectives D Lawin, UV Albrecht, ZS Oftring, T Lawrenz, C Stellbrink, S Kuhn Der Internist 63 (3), 274-280, 2022 | 1 | 2022 |
| Alcohol-induced right bundle branch block is associated with a benign outcome in HOCM after alcohol septum ablation (ASA) D Lawin, T Lawrenz, K Radke, A Wolff, C Stellbrink Clinical Research in Cardiology, 1-11, 2022 | 1 | 2022 |
| Seismocardiography with smartphones: no leap from bench to bedside (yet) UV Albrecht, D Lawin, S Kuhn, U Kulau Advances in Informatics, Management and Technology in Healthcare, 271-275, 2022 | 1 | 2022 |
| Transvenous neurostimulation in central sleep apnea associated with heart failure C Stellbrink, B Hansky, P Baumann, D Lawin Herzschrittmachertherapie+ Elektrophysiologie 29, 377-382, 2018 | 1 | 2018 |
| Heart on a string: a novel approach to managing difficult access to the left pericardiacophrenic vein for phrenic nerve stimulation. D Lawin, B Hansky, P Baumann, C Stellbrink Herzschrittmachertherapie & Elektrophysiologie 29 (3), 322-324, 2018 | 1 | 2018 |
| Use of class IC antiarrhythmic drugs in patients with structural heart disease and implantable cardioverter defibrillator MM Zylla, J Wolfes, R Schleberger, D Lawin, M Kieser, F Reinke, ... Clinical Research in Cardiology, 1-9, 2024 | | 2024 |
| Myosin Inhibitors for Hypertrophic Obstructive Cardiomyopathy (HOCM): Is HOCM passing another Crossroad? T Lawrenz, D Lawin, C Stellbrink Canadian Journal of Cardiology, 2024 | | 2024 |
